The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens
Open accessAbstract
1. This study was directed at exploring the structure-activity relationship for anandamide and certain of its analogues at the rat VR1 receptor in transfected cells and at investigating the relative extent to which anandamide interacts with CB(1) and vanilloid receptors in the mouse vas deferens. 2. pK(i) values for displacement of [(3)H]-resiniferatoxin from membranes of rVR1 transfected CHO cells were significantly less for anandamide (5.78) than for its structural analogues N-(4-hydroxyphenyl)-arachidonylamide (AM404; 6.18) and N-(3-methoxy-4-hydroxy)benzyl-arachidonylamide (arvanil; 6.77). 3. pEC(50) values for stimulating (45)Ca(2+) uptake into rVR1 transfected CHO cells were significantly less for anandamide (5.80) than for AM404 (6.32) or arvanil (9.29). Arvanil was also significantly more potent than capsaicin (pEC(50)=7.37), a compound with the same substituted benzyl polar head group as arvanil. 4. In the mouse vas deferens, resiniferatoxin was 218 times more potent than capsaicin as an inhibitor of electrically-evoked contractions. Both drugs were antagonized to a similar extent by capsazepine (pK(B)=6.93 and 7.18 respectively) but were not antagonized by SR141716A (1 microM). Anandamide was less susceptible than capsaicin to antagonism by capsazepine (pK(B)=6.02) and less susceptible to antagonism by SR141716A (pK(B)=8.66) than methanandamide (pK(B)=9.56). WIN55212 was antagonized by SR141716A (pK(B)=9.02) but not by capsazepine (10 microM). 5. In conclusion, anandamide and certain of its analogues have affinity and efficacy at the rat VR1 receptor. In the mouse vas deferens, which seems to express vanilloid and CB(1) receptors, both receptor types appear to contribute to anandamide-induced inhibition of evoked contractions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anandamide also acts as an endovanalloid at the transient receptor potential cation channel (TRPV1) receptor.31 AEA shows affinity for TRPV1 that is 5-20 fold lower than its affinity for CB1.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Vanilloid (Capsaicin) Receptors and Mechanisms
SZALLASI, A., & Blumberg, P. M. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01403-0 · Cited by 1,903
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,526
Bisogno, T., Hanuš, L., PETROCELLIS, L. D., Tchilibon, S., Ponde, D. E., Brandi, I., Moriello, A. S., Davis, J. B., Mechoulam, R., & Marzo, V. D. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704327 · Cited by 1,315
Hwang, S. W., Cho, H., Kwak, J., Lee, S.-Y., Kang, C.-J., Jung, J., Cho, S., Min, K. H., Suh, Y., Kim, D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.6155 · Cited by 1,047
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin
Bevan, S., Hothi, S. S., Hughes, G. A., James, I. F., Rang, H. P., Shah, K., Walpole, C. S. J., & Yeats, J. C. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb12781.x · Cited by 587
Flagged first, then by citations
Research works printed but not linked: 1
- SPINA D., 2000, Effect of the putative vanilloid receptor agonist, anandamide on the baseline tone in the guinea‐pig bronchus, Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol., 7, 60
Cited by
Sorted by citations
Items 201–237 of 237
Biochemical Pharmacology of TRPV1: Molecular Integrator of Pain Signals
Surowy, C. S., Kym, P. R., & Reilly, R. M. (2010) · Wiley eBooks · doi:10.1002/9780470588284.ch3 · Cited by 4
Il sistema endocannabinoide: attuali conoscenze e potenziali applicazioni in odontostomatologia
Pavanini, S., Lauriola, S., Mottola, A., & Cocchi, R. (2011) · Italian Oral Surgery · doi:10.1016/j.ios.2010.11.004 · Cited by 3
The Endocannabinoid System in Local and Systemic Inflammation
Kelly, M. E. M., Lehmann, C., & Zhou, J. (2017) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00151ed1v01y201702isp074 · Cited by 4
Okcay, Y., SİS, Ç. Ö., Ozpolat, M. C., Rumanlı, Z., Ulusoy, K. G., Yıldız, O., & Vural, İ. M. (2024) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.13008 · Cited by 4
“There are reports in the literature that CB 1 receptors and vanilloid receptors contribute to the anandamide-induced relaxation responses in mouse vas deferens tissues [15].”
Marijuana and Cannabinoid Research
Emmanuel, O. S. (2005) · Humana Press eBooks · doi:10.1385/1592599990 · Cited by 3
TRPV1 in Cell Signaling: Molecular Mechanisms of Function and Modulation
Rosenbaum, T., & Jara-Oseguera, A. (2012) · Springer eBooks · doi:10.1007/978-94-007-5073-9_3 · Cited by 2
Daniel, V. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_40 · Cited by 2
Vogel, H. G., Vogel, W. H., Schölkens, B. A., Sandow, J., Müller, G. A., & Vogel, W. F. (2002) · Springer eBooks · doi:10.1007/3-540-29837-1_2 · Cited by 2
Functional Selectivity at Receptors for Cannabinoids and Other Lipids
Howlett, A. C. (2009) · The Receptors · doi:10.1007/978-1-60327-335-0_11 · Cited by 2
Charrua, A., & Cruz, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18653-0.00007-1 · Cited by 1
Endocannabinoids and vanilloid TRPV1 receptors
Ross, R. A. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7379-2_5 · Cited by 1
“Whereas anandamide has similar affinity for TRPV1 to that of capsaicin, it has significantly lower potency [ 14 ].”
BackgroundInfluentialTanaka, K., Subramaniam, S., Atluri, S. C., Amoako, A. A., Mortlock, S., Montgomery, G. W., & McKinnon, B. D. (2024) · Cannabis and Cannabinoid Research · doi:10.1089/can.2024.0081 · Cited by 1
Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_2 · Cited by 1
Cannabinoid mediated diuresis in mice
Chopda, G. R. (2013) · doi:10.17760/d20196364
Olango, W. M. (2012) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17506 · Cited by 1
Gralinski, M., Neves, L. A. A., & Tiniakova, O. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_2 · Cited by 1
Makwana, R. (2007) · University of Hertfordshire Research Archive (University of Hertfordshire)
Effects of WIN 55,212-2 on IK Current in Cultured Trigeminal Ganglion Neurons of Rat
明章银, 谭艳, 付晖, 曹雪红, 潘建萍, 胡本容, 刘烈炬, & 向继洲 (2005) · 华中科技大学学报：医学英德文版
Effects of WIN 55, 212-2 onIK current in cultured trigeminal ganglion neurons of rat
Zhangyin, M., Yan, T., Fu, H., Cao, X., Jianping, P., Hu, B., Lieju, L., & Ji-zhou, X. (2005) · Current Medical Science · doi:10.1007/bf02873555
Breyne, J. (2006) · Ghent University Academic Bibliography (Ghent University)
Krustev, E. (2015) · DalSpace (Dalhousie University)
TRPV1 (VR-1) Vanilloid Receptor
Finn, D. P. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.60389-7
Functional Plasticity of Lipid Mediators
Marzo, V. D., PETROCELLIS, L. D., & van der Stelt, M. (2005) · CRC Press eBooks · doi:10.1201/9781420027655.ch3
TRP Channels in the Genitourinary Tract
Charrua, A., & Cruz, F. (2012) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-077-9_19
rat skeletal muscle arterioles and in CHO-TRPV1 cells by anandamide
Lizanecz, E., Bagi, Z. A., Pásztor, E. T., Papp, Z., Edes, I. F., Kedei, N., Blumberg, P. M., Tóth, A., & Zs, M. (2005)
Endocannabinoid metabolism : the impact of inflammatory factors and pharmacological inhibitors
Karlsson, J. (2018) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Daniel, V. (2014) · Springer eBooks · doi:10.1007/978-3-642-27728-3_40-1
Sampaio, M. D. F. D. S., de Paiva, Y. B., Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2023) · doi:10.22541/au.169747457.78026237/v1
Stadler, A. (2010) · mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)
Quillfeldt, J. A., & Alvares, L. D. O. (2026) · Springer eBooks · doi:10.1007/978-3-032-12239-1_3
Koob, G. F., Arends, M. A., McCracken, M. L., & Moal, M. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-12-816791-5.00001-7
Exploring natural non-cannabis sources of cannabinoid-based compounds: a review
Odieka, A. E., & Oyedeji, A. O. (2026) · Open Chemistry · doi:10.1515/chem-2025-0217
Metadata
- Authors
- Ross, R. A., Gibson, T. M., Brockie, H. C., Leslie, M., Pashmi, G., Craib, S. J., Di Marzo, V., & Pertwee, R. G.
- Affiliations
- University of Aberdeen (GB)
- Corresponding author
- Ross, Ruth A
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2001-02
- Volume
- 132
- Issue
- 3
- Pages
- 631-640
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572597
- OpenAlex
- W2021876302
- Cited by
- 237
- References
- 28
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 6 · 2017: 8 · 2016: 4 · 2015: 12 · 2014: 6 · 2013: 12 · 2012: 6
- FWCI
- 9.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- National Institute on Drug Abuse (P01DA009789, DA 09789)
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- anandamide, structure-activity relationship, vanilloid receptor 1, CB1 receptor, cannabinoid analogues, AM404, resiniferatoxin, capsaicin, vas deferens contraction, SR141716A, capsazepine, methanandamide, receptor binding affinity
- MeSH terms
- Rimonabant, Animals, Arachidonic Acids, Binding, Competitive, Biological Transport, Calcium, Calcium Channel Blockers, Cannabinoids, Capsaicin, Drug Interactions, Electric Stimulation, Enzyme Inhibitors, Cricetinae, Male, Morpholines, Muscle Contraction, Naphthalenes, Phenylmethylsulfonyl Fluoride, Piperidines, Pyrazoles, Radioligand Assay, Receptors, Drug, Structure-Activity Relationship, Transfection, Vas Deferens, CHO Cells, Receptors, Cannabinoid, Benzoxazines, TRPV Cation Channels, Mice, Polyunsaturated Alkamides, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
